Telix Pharmaceuticals Ltd

TLX



詳細チャートを表示

7.800USD

-0.010-0.13%

終値 12/19, 16:00（ET）15分遅れの株価

0.00時価総額

--直近12ヶ月PER



Telix Pharmaceuticals Ltd

7.800

-0.010-0.13%

概要企業名金融分析

概要

企業名

金融

分析

Intraday

30m

本日

-0.13%

5日間

-13.62%

1ヶ月

-11.06%

6ヶ月

-54.52%

年初来

-49.35%

1年間

-50.70%

詳細チャートを表示

TradingKey 株式スコア

データが不十分なため、株式スコアは利用できません。

Telix Pharmaceuticals Ltd ニュース

最新情報をお待ちください...

財務指標

EPS

会社から関連データがまだ開示されていません。

総売上高

会社から関連データがまだ開示されていません。

Telix Pharmaceuticals Ltdの企業情報

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.

企業コードTLX

企業名Telix Pharmaceuticals Ltd

最高経営責任者「CEO」Ortiz (Raphaeel)

ウェブサイトhttps://telixpharma.com/